Sarah Robinson, Ph.D.


Dr. Robinson (maiden name Baas) completed her graduate work at the University of Georgia in the laboratory of Dr. Michael Tiemeyer at the Complex Carbohydrate Research Center. Her work focused on the regulation of neural-specific glycosylation in the Drosophila embryo. After finishing her Ph.D. work, Dr. Robinson moved to Nashville to pursue postdoctoral work in the laboratory of Dr. Randy Blakely at Vanderbilt University.  There she switched to studying the small roundworm C. elegans, using it a model system to study novel regulators of dopamine signaling.


Dr. Robinson is currently a postdoctoral research fellow in the laboratory of Randy Blakely at Vanderbilt University.  She is studying the role of motifs in the C-terminus of the dopamine transporter that are required for proper synaptic localization of the transporter. She is also focused on the characterization of a novel mutation that arose from a forward genetic screen for novel regulators of the dopamine transporter.

Recent Publications

  1. Hardaway, J.A., Hardie, S., Whitaker, S., Baas, S., Zhang, B., Bermingham, D., Lichtenstein, A., and Blakely, R. (2012) Forward genetic analysis targeting endogenous dopamine inactivation in Caenorhabditis elegans using swimming induced paralysis, G3 2: 961-975.

Sarah Robinson, Ph.D.
Visiting Assistant Professor

Postdoctoral researcher in Department of Pharmacology, Vanderbilt University Medical Center
Ph.D. Biochemistry and Molecular Biology, University of Georgia
B.S. Biology, Virginia Tech

Hughes Kellog Research Building
1000 17th Ave. North,
Nashville, Tn 37208
Office: 615.329.8752